| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | 18.8× | 12.6× | |
| Price / Book | 1.0× | 2.9× | |
| Price / Sales | 0.8× | 1.3× | |
| Price / Free cash flow | 62.0× | 11.4× | |
| EV / EBITDA | 6.3× | 7.1× | |
| Earnings yield | 5.3% | 7.9% | |
| Free cash flow yield | 1.6% | 3.6% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
GLKAR:GLAXOGlaxoSmithKline Pakistan Ltd · 🇵🇰 KAR | Rs 314.87 | +0.28% | $360.56M | 9.9× | 29.8% | −21.4% |
ABKAR:ABOTAbbott Laboratories (Pakistan) Ltd · 🇵🇰 KAR | Rs 945.00 | −0.29% | $333.11M | 11.6× | 25.2% | −19.8% |
HAKAR:HALEONHaleon Pakistan Ltd · 🇵🇰 KAR | Rs 678.00 | +0.09% | $289.73M | 12.6× | 43.1% | −24.3% |
HIKAR:HINOONHighnoon Laboratories Ltd · 🇵🇰 KAR | Rs 943.89 | +0.60% | $179.49M | 12.0× | 30.0% | −18.6% |
AGKAR:AGPAGP Ltd · 🇵🇰 KAR | Rs 164.30 | −0.46% | $169.57M | 12.6× | 24.2% |
| −15.2% |
SEKAR:SEARLThe Searle Co Ltd · 🇵🇰 KAR | Rs 76.66 | +0.45% | $165.97M | 103.8× | 1.3% | −34.4% |
HPKAR:HPLHoechst Pakistan Ltd · 🇵🇰 KAR | Rs 4,030.30 | −0.62% | $139.74M | 13.4× | 35.4% | −3.4% |
CPKAR:CPHLCiti Pharma Ltd · 🇵🇰 KAR | Rs 62.50 | +0.24% | $51.02M | 15.8× | 8.2% | −29.1% |
BFKAR:BFBIOBF Biosciences Ltd · 🇵🇰 KAR | Rs 126.20 | +0.10% | $41.1M | 25.4× | 9.6% | −17.9% |
MAKAR:MACTERMacter International Ltd · 🇵🇰 KAR | Rs 242.00 | −0.31% | $40.49M | 16.5× | 16.2% | −28.7% |
